Member Info for CashFlow66

After such positive results definitely other deals and interested parties on the way.

Excellent news sustained patient results

Like I said yesterday RNS today

I have a feeling the news is out and a few tried to get it before the final bell. Tomorrow we know for sure.

I'll eat my hat if there isn't a RNS tomorrow morning after that dirty late buy that got us to 2.62.

The graph shows the trading pattern is definitely being triggered by someone computer algorithm. up and down at regular intervals desperate attempt to shake the tree and scare less experienced to sell up.

Egg I’m as keen as you for the arrival of the forthcoming RNS but from experience. These major RNS’s are released at 7am.

MM’s are gobbling these up they know a cash cow when they see one.

Thanks and Good Luck Canary. All the best with your ventures.

Noticed the need of someone to keep this below 250. Lets see how it plays out

That’s the way I see it too. Hence my previous posts.

Sir Chris Evans OBE adding again. He knows where this is going!

Well are rather be in Rene at the this time than tied into some share that had no potential. Directors know there’s potential to make good money and are buying in which is always a good sign.

Yup a few scattered to other boards. Hoping to scare holders into sell big up so they can get back in cheap.

This is almost a vertical rise last time this happened a very positive RNS followed.

I wonder if this upward movement is due to a leak of positive news.

Also most LTH are quite use to the mm tree shakes and profit taking dips. So my advice to any newbies is - don’t panic and enjoy the Brucey Bonus when it arrives.

Hi Manifesto I'm one of the 300/400% long term holders and have no intention of selling. There is far too much upside in this old dog and the chance of a Big Pharma Buyout nears ever closer.

Grizz was that your comment on the DM website...

HoardingB, not true at all. Current estimated cost per eye is ¿35k in the (EU) and $50k (US/Japan). ReNeuron has been in discussion with UK Government and NICE for many years regarding their stem cell therapies, they've also received government funding via. The Cell Therapy Catapault. One of the primary benefits of their cell therapies is the reduction in financial burden to the NHS.

Https://www.stockopedia.com/articles/reneuron-share-price-hits-a-new-52-week-high-2091/ Making sense of 52 week highs 52 week highs are always good news. But you might be surprised to know that the prices of high performing shares can be slow to move when these companies publish positive earnings news. Studies show it happens because investors are wary about bidding high performing shares any higher (even if they deserve it). This unusual behaviour is down to what the psychologists Amos Tversky and Daniel Kahneman called anchoring-and-adjustment. We form beliefs by using reference points (like share prices). But as new information comes to light (like earnings reports) we're often slow to update our beliefs away from the original anchor point. Evidence shows this tug-of-war usually ends with the ‘new high’ stock actually drifting higher in price over the coming weeks and months. The upward trend is called “post earnings announcement drift”. As the news sinks in, momentum takes over and the price moves higher. A look at Reneuron’s StockReport could offer more insight into what’s driving the momentum in its share price - and whether that might continue. If there is some positive media over the weekend the momentum may continue next week, if not there could be a slight pull back for a few days until people start to "speculate" on the details that could be shared on 26th April: Further read-outs from the patients treated in the Phase 1/2 study will be presented at the 6th Annual Retinal Cell and Gene Therapy Innovation Summit, taking place in Vancouver, Canada, on 26 April 2019. Information regarding this conference may be found at: Https://www.regonline.com/builder/site/default.aspx?EventID=2548135 Also good to see that RENE are being very active when it comes to conferences/events and will be in Kyoto at this event per the website (link below): Https://www.isev.org/page/ISEV2019 Http://www.reneuron.com/news/events/